Work

Rate of Viral Evolution and Risk of Losing Future Drug Options in Heavily Pretreated, HIV-Infected Patients Who Continue to Receive a Stable, Partially Suppressive Treatment Regimen

Year: 2006

Type: article

Study design: Observational Study

Source: Clinical Infectious Diseases

DOI: 10.1086/508655

Authors: H. Hatano, P. Hunt, J. Weidler, E. Coakley, R. Hoh, T. Liegler, J. N. Martin, S. G. Deeks

Institutions: University of California, San Francisco, Gladstone Institutes

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Small Business Innovation Research, National Institutes of Health, Center for AIDS Research, University of Washington, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, National Center for Research Resources, Center for AIDS Prevention Studies, University of California, San Francisco

Awards: G1572886882, HIV-1 Therapeutics and Drug Resistance, UCSF-GIVI CENTER FOR AIDS RESEARCH, G200995756, G2851603639, A novel assay for measuring HIV-1 replication capacity, General Clinical Research Center, G4869482613, G5418282550, Immunologic Control of Drug-resistant HIV-1, G6091318935, G6506815201, G7998845928, G817638440, Center for AIDS Prevention Studies (CAPS), UCSF-Bay Area Center for AIDS Research

OpenAlex ID: W2146935866

FWCI: 6.688

Cites: 31

Cited by: 72

Related to: 10